Shivom: The Hard Questions
Shivom is one of the most revolutionaries new startups in the market of digital currencies right now, the team behind the brand has envisioned a future where genomic data has become a universal asset offering all the information to build the profile of every single living person for medical purposes. They are currently working to create the first-ever genetic ecosystem to carry out their vision of personalized medical attention powered by Blockchain Technology. The data-driven tool will be able to handle the information of each user using state-of-the-art AI technology along every healthcare system around the world to handle the information of patients and donors by using smart contracts.
Why should you consider The Service?
The most direct answer is “data safety,” let’s elaborate on this: by working with Shivom, every user is choosing to work with one of the most secure and reliable ways to handle their own genome data. Using the Blockchain log, every user will have a recording of their DNA structure to make it available to companies looking to work with this type of information to develop scientific studies that might lead to the cure of an illness. Lending this information is not an altruistic transaction since every user will be able to collect rewards from it. They will also have control over the amount of data shared as well as the third parties that request and get access to it.
How does it Work?
The process is quite easy and not time-consuming at all. As soon as a user signs up with Shivom, they should be getting a kit in the mail to allow the company to upload their DNA sequence. Users have to collect a sample of their saliva and send it back to the company’s quarters where a team of medical specialists will break down the user’s DNA code to offer knowledge about the ancestry, or get personalized health insight. The information will be stored in the decentralized network of the company, and the user will be able to share their genome information for research purposes for free or by requesting profits from it.
Why do This Now?
If you remember science history for a minute, you might recall that the first time human DNA was broken down and studied, it took 18 years to complete and 3 billion dollars, the team working on this task started in 1985 and ended in 2003. These days the cost of that same study has fallen because it’s very common. The team behind Shivom considers that by the end of this decade, a human’s DNA will be mapped out by less than $100. The analyses that are derivative of this mapping will fall to even lower costs, and medical companies will enter in a fierce competition to offer the cheapest services tied to DNA tracking, very much in the same fashion as it happened with pregnancy tests years ago.
What are the Benefits?
In the current stage of the market genomic sequencing can provide some benefits such as the chance to identify the best way to treat a patient with a specific condition, the prevention of diseases in general. The means to predict a health hazard, a way to get a functioning diagnose that won’t build paranoia unlike most symptoms Google searches, the right treatment to minor diseases and the option to follow the development of new drugs that might help treat a pre-existing condition in a better way. These, of course, are just a scratch on the surface of what it can be achieved with Shivom, to learn more about them you can visit:
Judging from the negative point I have raised, the project does not sound of investment quality. However, the overall concept of the platform is unique, and the venture could face a revisit if the inefficiencies get the adequate solutions.